Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy

Completed

Conditions studied: Non-Small Cell Lung Cancer

In brief

This study aims to look at a comparison of liquid biopsy (blood sample) analysis compared with tissue biopsy in patients with advanced lung cancer

Key facts

Study ID

NCT03116633

Run by

Inivata

People needed

34

Starts

2017-06-30

Expected to finish

2018-12-31

Last updated by the study team

2019-05-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written, signed and dated informed consent
• Male \& female patients aged 18 years and over diagnosed with stage IIIb/IV non-squamous NSCLC.
• Patients intended to initiate first-line treatment (Arms A and B)
• Patients who plan to have or have had a recent tumor tissue biopsy taken as part of their standard of care (Arm A)
• Patient must understand and be able, willing and likely to fully comply with all study procedures and restrictions.

You may not qualify if…

• Patients who have received any approved or experimental cancer therapy since their most recent NSCLC tissue biopsy
• Any history of metastatic cancer.
• Previous malignancy in the last 2 years (except basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix).
• Patient with a severe acute or chronic medical or psychiatric condition or laboratory abnormality

Where it is running

• Mercy Hospital Cancer Center/Clinical Research — Fort Smith, Arkansas, United States
• Mercy Cancer Center — Joplin, Missouri, United States
• Mercy Clinic — Springfield, Missouri, United States
• Mercy Clinic Oncology & Hematology — Oklahoma City, Oklahoma, United States
• Lehigh Valley Health Networks — Allentown, Pennsylvania, United States
• Gibbs Cancer Center & Research Institute — Spartanburg, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.